Publications by authors named "Leonard B Seeff"

Claim this Profile
G
Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury.
Raj Vuppalanchi, Herbert L Bonkovsky, Jawad Ahmad, Huiman Barnhart, Francisco Durazo, Leonard B Seeff

Clin Gastroenterol Hepatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence.
Marc G Ghany, Anna S F Lok, Jules L Dienstag, Stephen M Feinstone, Jay H Hoofnagle, Leonard B Seeff

Hepatology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-B*35:01 and Green Tea-Induced Liver Injury.
Jay H Hoofnagle, Herbert L Bonkovsky, Elizabeth J Phillips, Yi-Ju Li, Jawad Ahmad, Leonard B Seeff

Hepatology· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman.
James H Lewis, Leonard B Seeff

Clin Liver Dis (Hoboken)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.
Hellen A Oketch-Rabah, Amy L Roe, Cynthia V Rider, Herbert L Bonkovsky, Gabriel I Giancaspro, Leonard B Seeff

Toxicol Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
Andrew Stolz, Victor Navarro, Paul H Hayashi, Robert J Fontana, Huiman X Barnhart, Leonard B Seeff

Aliment Pharmacol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver injury from herbal and dietary supplements.
Victor J Navarro, Ikhlas Khan, Einar Björnsson, Leonard B Seeff, Jose Serrano

Hepatology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Induced Liver Injury Is a Major Risk for New Drugs.
Leonard B Seeff

Dig Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.
Mark I Avigan, Robert P Mozersky, Leonard B Seeff

Int J Mol Sci· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herbal products and the liver: a review of adverse effects and mechanisms.
Leonard B Seeff, Herbert L Bonkovsky, Victor J Navarro, Guqi Wang

Gastroenterology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causality assessment for suspected DILI during clinical phases of drug development.
Arie Regev, Leonard B Seeff, Michael Merz, Sif Ormarsdottir, Guruprasad P Aithal

Drug Saf· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
Victor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, Timothy Davern, Robert J Fontana, Leonard B Seeff

Hepatology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver injury induced by herbal complementary and alternative medicine.
Victor J Navarro, Leonard B Seeff

Clin Liver Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained virologic response: is this equivalent to cure of chronic hepatitis C?
Leonard B Seeff

Hepatology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief history of the treatment of viral hepatitis C.
Doris B Strader, Leonard B Seeff

Clin Liver Dis (Hoboken)· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.
Richard K Sterling, Elizabeth C Wright, Timothy R Morgan, Leonard B Seeff, John C Hoefs

Am J Gastroenterol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.
Marc G Ghany, Hae-Young Kim, Anne Stoddard, Elizabeth C Wright, Leonard B Seeff

Hepatology· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.
Marc G Ghany, David R Nelson, Doris B Strader, David L Thomas, Leonard B Seeff

Hepatology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Jules L Dienstag, Marc G Ghany, Timothy R Morgan, Adrian M Di Bisceglie, Herbert L Bonkovsky, Leonard B Seeff

Hepatology· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Adrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, Mitchell L Shiffman, Leonard B Seeff

Hepatology· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of untreated and nonresponder patients with chronic hepatitis C.
Leonard B Seeff, Marc G Ghany

Semin Liver Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
Leonard B Seeff, Gregory T Everson, Timothy R Morgan, Teresa M Curto, William M Lee

Clin Gastroenterol Hepatol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.
Robert J Fontana, Leonard B Seeff, Raúl J Andrade, Einar Björnsson, Christopher P Day

Hepatology· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatotoxicity due to hydroxycut: a case series.
Tse-Ling Fong, Karl C Klontz, Alejandro Canas-Coto, Steven J Casper, Francisco A Durazo, Leonard B Seeff

Am J Gastroenterol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
Don C Rockey, Leonard B Seeff, James Rochon, James Freston, Naga Chalasani

Hepatology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis